GCLC
Glutamate--cysteine ligase catalytic subunit
Also known as: GCS, GLCL, GLCLC, GSH1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P48506
- Gene
- GCLC
- Ensembl
- ENSG00000001084
- Chromosome
- 6
- Canonical length
- 637 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli,Cytosol
OverviewNCBI Gene
Glutamate-cysteine ligase, also known as gamma-glutamylcysteine synthetase is the first rate-limiting enzyme of glutathione synthesis. The enzyme consists of two subunits, a heavy catalytic subunit and a light regulatory subunit. This locus encodes the catalytic subunit, while the regulatory subunit is derived from a different gene located on chromosome 1p22-p21. Mutations at this locus have been associated with hemolytic anemia due to deficiency of gamma-glutamylcysteine synthetase and susceptibility to myocardial infarction.[provided by RefSeq, Oct 2010]
Canonical amino-acid sequenceUniProt
637 residues, UniProt reviewed canonical sequence.
>P48506|GCLC
1 MGLLSQGSPL SWEETKRHAD HVRRHGILQF LHIYHAVKDR HKDVLKWGDE VEYMLVSFDH
61 ENKKVRLVLS GEKVLETLQE KGERTNPNHP TLWRPEYGSY MIEGTPGQPY GGTMSEFNTV
121 EANMRKRRKE ATSILEENQA LCTITSFPRL GCPGFTLPEV KPNPVEGGAS KSLFFPDEAI
181 NKHPRFSTLT RNIRHRRGEK VVINVPIFKD KNTPSPFIET FTEDDEASRA SKPDHIYMDA
241 MGFGMGNCCL QVTFQACSIS EARYLYDQLA TICPIVMALS AASPFYRGYV SDIDCRWGVI
301 SASVDDRTRE ERGLEPLKNN NYRISKSRYD SIDSYLSKCG EKYNDIDLTI DKEIYEQLLQ
361 EGIDHLLAQH VAHLFIRDPL TLFEEKIHLD DANESDHFEN IQSTNWQTMR FKPPPPNSDI
421 GWRVEFRPME VQLTDFENSA YVVFVVLLTR VILSYKLDFL IPLSKVDENM KVAQKRDAVL
481 QGMFYFRKDI CKGGNAVVDG CGKAQNSTEL AAEEYTLMSI DTIINGKEGV FPGLIPILNS
541 YLENMEVDVD TRCSILNYLK LIKKRASGEL MTVARWMREF IANHPDYKQD SVITDEMNYS
601 LILKCNQIAN ELCECPELLG SAFRKVKYSG SKTDSSNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GCLC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 142 nTPM
Expression across tissuesHPA
Tissue
- liver: 142 nTPM
- urinary bladder: 60 nTPM
- fallopian tube: 59 nTPM
- duodenum: 40 nTPM
- spleen: 37 nTPM
- bone marrow: 36 nTPM
Single-cell type
- urothelial cells: 1,134 nCPM
- neuroendocrine cells: 359 nCPM
- prostatic hillock cells: 342 nCPM
- respiratory ciliated cells: 306 nCPM
- basal keratinocytes: 299 nCPM
- kupffer cells: 253 nCPM
Immune cell
- NK-cell: 4.2 nTPM
- myeloid DC: 2.3 nTPM
- plasmacytoid DC: 1.6 nTPM
- basophil: 1.2 nTPM
- memory CD8 T-cell: 1.1 nTPM
- non-classical monocyte: 1 nTPM
Brain region
- white matter: 70 nTPM
- basal ganglia: 48 nTPM
- thalamus: 44 nTPM
- medulla oblongata: 40 nTPM
- midbrain: 38 nTPM
- cerebral cortex: 38 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GCLC.
Disease | AllUniProt
Conditions GCLC is implicated in, by any mechanism.
- Anemia, congenital, non-spherocytic hemolytic, 7 (CNSHA7) MIM:230450
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 234 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Gamma-glutamylcysteine synthetase deficiency
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.4
- gnomAD pLI
- 0.43
- gnomAD missense Z
- 2.55
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- blood vessel diameter maintenance
- cell redox homeostasis
- cellular response to fibroblast growth factor stimulus
- cellular response to follicle-stimulating hormone stimulus
- cellular response to glucose stimulus
- cellular response to hepatocyte growth factor stimulus
- cellular response to insulin stimulus
- cellular response to mechanical stimulus
- cellular response to thyroxine stimulus
- cysteine metabolic process
- glutamate metabolic process
- glutathione biosynthetic process
- L-ascorbic acid metabolic process
- negative regulation of apoptotic process
- negative regulation of DNA-templated transcription
- negative regulation of extrinsic apoptotic signaling pathway
- negative regulation of hepatic stellate cell activation
- negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
- negative regulation of neuron apoptotic process
- negative regulation of protein ubiquitination
- positive regulation of proteasomal ubiquitin-dependent protein catabolic process
- regulation of mitochondrial depolarization
- response to activity
- response to arsenic-containing substance
- response to cadmium ion
- response to heat
- response to hormone
- response to human chorionic gonadotropin
- response to interleukin-1
- response to nitrosative stress
- response to nutrient
- response to oxidative stress
- response to xenobiotic stimulus
Molecular functions
- ADP binding
- ATP binding
- glutamate binding
- glutamate-cysteine ligase activity
- magnesium ion binding
- protein-containing complex binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Glutamine synthetase/guanido kinase, catalytic domain
- Glutamate-cysteine ligase catalytic subunit
- Glutamate-cysteine ligase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GCLC in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GCLC as an antibody target. Whether an autoantibody or antibody against GCLC could matter depends on whether native GCLC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GCLC is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GCLC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...